Pulse Biosciences (PLSE) Assets (2015 - 2026)

Pulse Biosciences has reported Assets for 12 years, with the latest figure at $115.6 million in Q2 2026.

• On a quarterly basis, Assets fell 3.9% year-over-year to $115.6 million in Q2 2026; TTM through Jun 2026 was $115.6 million, a 3.9% decrease from a year earlier, with the FY2025 full-year figure at $94.5 million, down 28.63% from the prior year.
• Assets was $115.6 million for Q2 2026 at Pulse Biosciences, up from $94.5 million in the prior quarter.
• The five-year high for Assets was $133.4 million in Q1 2025, with the low at $39.5 million in Q1 2022.
• Average Assets over 5 years is $82.5 million, with a median of $77.9 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Assets plunged 50.92% in 2022, then jumped 197.44% in 2025.
• Over 5 years, Assets stood at $77.9 million in 2022, then declined by 24.04% to $59.2 million in 2023, then jumped by 123.92% to $132.5 million in 2024, then decreased by 28.63% to $94.5 million in 2025, then grew by 22.24% to $115.6 million in 2026.
• The last three Assets figures came in at $115.6 million (Q2 2026), $94.5 million (Q4 2025), and $108.8 million (Q3 2025), per Business Quant data.